If you have been diagnosed with age-related macular degeneration (AMD), it is important to understand the treatment options available to you.
A simple in-office procedure, 2RT™ Retinal Rejuvenation is a breakthrough technology that uses laser light to slow the progression of AMD to late-stage disease.
Repeated ongoing eye injections (anti-VEGF) are suitable for the wet, late-stage of AMD. In contrast, 2RT™ Retinal Rejuvenation is applied much earlier in the disease process as an intervention for intermediate AMD.
We are thrilled to announce that 2RT® Retinal Rejuvenation Therapy now forms part of Nova Eye Medical Limited.
From our base in Fremont, California, our team is working hard to develop 2RT® as a potential breakthrough therapy for patients with intermediate age-related macular degeneration (iAMD).